Table 1.
Variables | Study participants (n = 211) |
---|---|
Age, mean ± SD (year) | 58.34 ± 12.08 |
Male sex [n (%)] | 142 (67.3) |
BMI, median (IQR) (kg/m2) | 23.39 (22.26–24.66) |
Smoking history [n (%)] | 38 (18.0) |
Alcohol history [n (%)] | 27 (12.8) |
Hypertension [n (%)] | 151 (71.6) |
Diabetes mellitus [n (%)] | 3 (1.4) |
Coronary heart disease [n (%)] | 13 (6.2) |
Stroke history [n (%)] | 17 (8.1) |
Antithrombotic agent history [n (%)] | 6 (2.8) |
The degree of coma (GCS score) [n (%)] | |
Level 1 (13–15 points) | 96 (45.5) |
Level 2 (9–12 points) | 41 (19.4) |
Level 3 (3–8 points) | 74 (35.1) |
Supratentorial hemorrhage [n (%)] | |
Basal ganglia | 82 (38.9) |
Lobar | 66 (31.3) |
Thalamus | 54 (25.6) |
Infratentorial hemorrhage [n (%)] | |
Brainstem | 16 (7.6) |
Cerebellum | 14 (6.6) |
IVH [n (%)] | 106 (50.2) |
SAH [n (%)] | 35 (16.6) |
Large hematoma [n (%)] | 88 (41.7) |
Hematoma volume, median (IQR) (ml) | 18.50 (7.94–43.70) |
Hematoma volume at various hemorrhagic locations | |
Basal ganglia, median (IQR) (ml) | 24.38 (12.86–50.40) |
Lobar, median (IQR) (ml) | 22.33 (9.64–47.63) |
Thalamus, median (IQR) (ml) | 17.72 (7.34–43.53) |
Brainstem, median (IQR) (ml) | 7.05 (2.86–15.34) |
Cerebellum, median (IQR) (ml) | 11.25 (5.91–25.22) |
Laboratory examination | |
TG, median (IQR) (mmol/l) | 0.95 (0.73–1.36) |
HDL, mean ± SD (mmol/l) | 1.21 ± 0.34 |
LDL, mean ± SD (mmol/l) | 2.43 ± 0.91 |
TC, mean ± SD (mmol/l) | 4.07 ± 1.11 |
Hemoglobin, mean ± SD (g/l) | 165.03 ± 34.12 |
Platelet count, mean ± SD (109/l) | 188.31 ± 71.49 |
Surgical operation [n (%)] | 45 (21.3) |
mRS 4–6 [n (%)] | 89 (42.2) |
BMI Body mass index, GCS Glasgow Coma Scale, HDL high-density lipoprotein cholesterol, ICH intracerebral hemorrhage, IQR interquartile range, IVH intraventricular hemorrhage, LDL low-density lipoprotein cholesterol, mRS Modified Rankin Scale, SAH subarachnoid hemorrhage, SD standard deviation, TC total cholesterol, TG triglycerides